No Impact of HIV-1 Protease Minority Resistant Variants on the Virological Response to a First-Line PI-based Regimen Containing Darunavir or Atazanavir - Sorbonne Université
Article Dans Une Revue Journal of Antimicrobial Chemotherapy Année : 2018

No Impact of HIV-1 Protease Minority Resistant Variants on the Virological Response to a First-Line PI-based Regimen Containing Darunavir or Atazanavir

Dates et versions

hal-03793517 , version 1 (01-10-2022)

Identifiants

Citer

Marine Perrier, Benoit Visseaux, Roland Landman, Véronique Joly, Eve Todesco, et al.. No Impact of HIV-1 Protease Minority Resistant Variants on the Virological Response to a First-Line PI-based Regimen Containing Darunavir or Atazanavir. Journal of Antimicrobial Chemotherapy, 2018, 73 (1), pp.173--176. ⟨10.1093/jac/dkx366⟩. ⟨hal-03793517⟩
23 Consultations
0 Téléchargements

Altmetric

Partager

More